Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1989 2
1990 1
1991 2
1992 4
1994 3
1995 2
1996 1
1997 6
1998 7
1999 3
2000 1
2001 2
2003 2
2005 4
2006 4
2007 1
2009 3
2010 3
2011 1
2012 1
2013 1
2014 1
2015 2
2016 2
2017 1
2019 2
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Inflammation Regulation by Bacterial Molecular Patterns.
Guryanova SV, Kataeva A. Guryanova SV, et al. Biomedicines. 2023 Jan 11;11(1):183. doi: 10.3390/biomedicines11010183. Biomedicines. 2023. PMID: 36672691 Free PMC article.
The aim of this investigation was to study the dynamic changes in the gene expression of A20 and ATF3, the inflammation suppressors, against the background of the expression of the genes of the innate immunity receptors TLR4 and NOD2 and the pro-inflammatory cytokine TNF-alpha un …
The aim of this investigation was to study the dynamic changes in the gene expression of A20 and ATF3, the inflammation suppressors, against …
Combined effects of synthetic lipid A analogs or bacterial lipopolysaccharide with glucosaminylmuramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice.
Shimizu T, Iwamoto Y, Yanagihara Y, Ikeda K, Achiwa K. Shimizu T, et al. Int J Immunopharmacol. 1992 Nov;14(8):1415-20. doi: 10.1016/0192-0561(92)90013-b. Int J Immunopharmacol. 1992. PMID: 1464473
The combined effects of the synthetic glucosaminylmuramyl dipeptide (GMDP) on the antitumor activity of chemically synthesized lipid A analogs, compound A-103 (glucosamine-4-phosphate with (R)-3-tetradecanoyloxytetradecanoyl group at the C-2 and C-3 positions), Esch …
The combined effects of the synthetic glucosaminylmuramyl dipeptide (GMDP) on the antitumor activity of chemically synthesized …
Dual Effect of Low-Molecular-Weight Bioregulators of Bacterial Origin in Experimental Model of Asthma.
Guryanova SV, Gigani OB, Gudima GO, Kataeva AM, Kolesnikova NV. Guryanova SV, et al. Life (Basel). 2022 Jan 27;12(2):192. doi: 10.3390/life12020192. Life (Basel). 2022. PMID: 35207480 Free PMC article.
In the present study, we analyzed cellular and humoral factors in a standard mouse model of OVA-induced asthma modified by 5-fold intraperitoneal injection of bacterial cell wall fragments of glucosaminylmuramyl dipeptide (GMDP) 5 mug/animal or 1 mug lipopolysacchar …
In the present study, we analyzed cellular and humoral factors in a standard mouse model of OVA-induced asthma modified by 5-fold intraperit …
[Use of probiotics and probiotic-based immunomodulators as adjuvant therapy for Helicobacter pylori eradication].
Konorev MR, Andronova TM, Matveenko ME. Konorev MR, et al. Ter Arkh. 2016;88(12):140-148. doi: 10.17116/terarkh20168812140-148. Ter Arkh. 2016. PMID: 28635890 Review. Russian.
The intake of licopid 0.001 and 0.01 g/day during 7-day triple anti-Hp therapy results in the absence of recurrent Hp infection, as compared with 7- and 14-day treatment protocols without licopid, and leads to a significantly low incidence of Hp reinfection within 2-5 years after …
The intake of licopid 0.001 and 0.01 g/day during 7-day triple anti-Hp therapy results in the absence of recurrent Hp infection, as compared …
Endogenous tumour necrosis factor-alpha sensitise melanoma cells to glucosaminylmuramyl dipeptide.
Valyakina TI, Komaleva RL, Petrova EE, Malakhov AA, Shamborant OG, Andronova TM, Nesmeyanov VA. Valyakina TI, et al. FEBS Lett. 1998 Apr 24;426(3):373-6. doi: 10.1016/s0014-5793(98)00376-7. FEBS Lett. 1998. PMID: 9600269 Free article.
Flow cytometry was used to demonstrate that cultured human melanoma BRO cells expressed membrane-bound tumour necrosis factor-alpha (TNF-alpha) and were able to release TNF-alpha upon treatment with glucosaminylmuramyl dipeptide (GMDP). The released TNF-alpha was sh …
Flow cytometry was used to demonstrate that cultured human melanoma BRO cells expressed membrane-bound tumour necrosis factor-alpha (TNF-alp …
[Muramyldipeptide - based compounds in current medicine: focus on glucosaminylmuramyl dipeptide].
Ushkalova EA, Zyryanov SK, Zatolochina KE. Ushkalova EA, et al. Ter Arkh. 2019 Dec 15;91(12):122-127. doi: 10.26442/00403660.2019.12.000471. Ter Arkh. 2019. PMID: 32598599 Russian.
The article describes the mechanisms of action of muramylpeptides, their biological effects and properties of medicines developed on their basis. Special emphasis is placed to glucosaminylmuramyl dipeptide registered in the Russian Federation under the trade name Li …
The article describes the mechanisms of action of muramylpeptides, their biological effects and properties of medicines developed on their b …
Glucosaminylmuramyl dipeptide (GMDP) modulates endothelial cell activities in vitro but has no effect on angiogenesis in vivo.
Li CG, Kumar S, Ledger PW, Ponting JM, Carette M, Allan E. Li CG, et al. Inflamm Res. 1997 Sep;46(9):348-53. doi: 10.1007/s000110050200. Inflamm Res. 1997. PMID: 9339390
MATERIALS: Human umbilical vein endothelial cells (HUVEC), fertilized white leghorn chicken eggs, antibodies against adhesion molecules and glucosaminylmuramyl dipeptide (GMDP). TREATMENT: GMDP [0.01-100 micrograms/ml] applied to cell cultures for 6-72 h and to the …
MATERIALS: Human umbilical vein endothelial cells (HUVEC), fertilized white leghorn chicken eggs, antibodies against adhesion molecules and …
Glucosaminylmuramyl dipeptide potentiates the effects of tumor necrosis factor-alpha and cisplatin on transformed cells in vitro.
Petrova EE, Valyakina TI, Komaleva RL, Simonova MA, Nesmeyanov VA. Petrova EE, et al. Bull Exp Biol Med. 2007 Feb;143(2):251-4. doi: 10.1007/s10517-007-0063-5. Bull Exp Biol Med. 2007. PMID: 17970214
At the same time, glucosaminylmuramyl dipeptide did not modulate the cytotoxic effect of individual or combined treatment with cisplatin and TNF-alpha on normal cells. Administration of glucosaminylmuramyl dipeptide to cultured MCF-7 cells 20 h before …
At the same time, glucosaminylmuramyl dipeptide did not modulate the cytotoxic effect of individual or combined treatment with …
64 results